Mercadante S - Search Results

1

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients.

Bonora S, Calcagno A, Vigano O, Bigliano P, Marinaro L, Colella E, Orofino G, Trentini L, Tettoni MC, D'Avolio A, Mercadante S, Galli M, Di Perri G, Rusconi S. Bonora S, et al. Among authors: mercadante s. Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616. Curr HIV Res. 2014. PMID: 25106410

2

Outcome of opioid switching 4 weeks after discharge from a palliative care unit.

Mercadante S, Ferrera P, Casuccio A. Mercadante S, et al. Curr Med Res Opin. 2011 Dec;27(12):2357-60. doi: 10.1185/03007995.2011.635197. Epub 2011 Nov 4. Curr Med Res Opin. 2011. PMID: 22029619

3

Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain.

Mercadante S, Porzio G, Adile C, Aielli F, Cortegiani A, Dickenson A, Casuccio A. Mercadante S, et al. Curr Med Res Opin. 2014 Oct;30(10):2063-8. doi: 10.1185/03007995.2014.934793. Epub 2014 Jun 27. Curr Med Res Opin. 2014. PMID: 24926734

4

Assessing age and gender in studies of breakthrough pain medications.

Mercadante S, Giarratano A. Mercadante S, et al. Curr Med Res Opin. 2014 Jul;30(7):1353-6. doi: 10.1185/03007995.2014.901942. Epub 2014 Mar 26. Curr Med Res Opin. 2014. PMID: 24625119 Review.

5

A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.

Mercadante SL, Berchovich M, Casuccio A, Fulfaro F, Mangione S. Mercadante SL, et al. Am J Hosp Palliat Care. 2007 Feb-Mar;24(1):13-9. doi: 10.1177/1049909106295431. Am J Hosp Palliat Care. 2007. PMID: 17347500 Clinical Trial.

6

Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life.

Mercadante S, Catala E, Arcuri E, Casuccio A. Mercadante S, et al. J Pain Symptom Manage. 2003 Dec;26(6):1140-7. doi: 10.1016/j.jpainsymman.2003.04.004. J Pain Symptom Manage. 2003. PMID: 14654266 Free article. Clinical Trial.

7

Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.

Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A. Mercadante S, et al. J Pain Symptom Manage. 2004 Apr;27(4):352-9. doi: 10.1016/j.jpainsymman.2003.09.006. J Pain Symptom Manage. 2004. PMID: 15050663 Free article.

8

Dialogues on complex analgesic strategies for difficult pain syndromes.

Mercadante S, Villari P, Ferrera P. Mercadante S, et al. Support Care Cancer. 2004 Aug;12(8):599-603. doi: 10.1007/s00520-003-0575-0. Epub 2004 Apr 9. Support Care Cancer. 2004. PMID: 15083354

9

Addition of a second opioid may improve opioid response in cancer pain: preliminary data.

Mercadante S, Villari P, Ferrera P, Casuccio A. Mercadante S, et al. Support Care Cancer. 2004 Nov;12(11):762-6. doi: 10.1007/s00520-004-0650-1. Support Care Cancer. 2004. PMID: 15206014 Clinical Trial.

10

Optimization of opioid therapy for preventing incident pain associated with bone metastases.

Mercadante S, Villari P, Ferrera P, Casuccio A. Mercadante S, et al. J Pain Symptom Manage. 2004 Nov;28(5):505-10. doi: 10.1016/j.jpainsymman.2004.02.024. J Pain Symptom Manage. 2004. PMID: 15504626 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters